NADP+ binding to the regulatory subunit of methionine adenosyltransferase II increases intersubunit binding affinity in the hetero-trimer by González, Beatriz et al.
  
1 
1 
NADP
+
 BINDING TO THE REGULATORY SUBUNIT OF METHIONINE 
ADENOSYLTRANSFERASE II INCREASES INTERSUBUNIT BINDING 
AFFINITY IN THE HETERO-TRIMER 
 
Beatriz González
1*
, Francisco Garrido
2*
, Rebeca Ortega
1
, Marta Martínez-Júlvez
3,4
, 
Ainhoa Revilla-Guarinos
2
, Yolanda Pérez-Pertejo
5
, Adrián Velázquez-Campoy
3,4,6
, 
Julia Sanz-Aparicio
1
, María A. Pajares
2,7! 
   
1
Departamento de Cristalografía y Biología Estructural, Instituto de Química-Física 
“Rocasolano” (CSIC), Serrano 119, 28006 Madrid, Spain. 
2
Instituto de Investigaciones 
Biomédicas “Alberto Sols” (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain. 
3
Departmento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, 
Pedro Cerbuna 12, 50009 Zaragoza, Spain. 
4
Instituto de Biocomputación y Física de 
Complejos, Unidad Asociada IQFR-BIFI, Mariano Esquillor s/n, Edificio I+D, Campus 
Rio Ebro, 50018 Zaragoza, Spain. 
5
Departamento de Farmacología y Toxicología 
(INTOXCAL), Universidad de León, Campus de Vegazana s/n, 24071 León, Spain. 
6
Fundacion ARAID, Diputación General de Aragón, Spain. 
7
Molecular Hepatology 
group, IdiPAZ, Pº de la Castellana 261, 28046 Madrid, Spain. 
 
!To whom correspondence should be addressed: Instituto de Investigaciones 
Biomédicas Alberto Sols (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain 
(Phone: 34-915854414; FAX: 34-915854401; email: mapajares@iib.uam.es) 
* These authors contributed equally to this work 
 
 
 
  
2 
2 
ABSTRACT 
 Mammalian methionine adenosyltransferase II (MAT II) is the only hetero-
oligomer in this family of enzymes that synthesize S-adenosylmethionine using 
methionine and ATP as substrates. Binding of regulatory " subunits and catalytic #2 
dimers is known to increase the affinity for methionine, although scarce additional 
information about this interaction is available. This work reports the use of recombinant 
#2 and " subunits to produce oligomers showing kinetic parameters comparable to 
MAT II purified from several tissues. According to isothermal titration calorimetry data 
and densitometric scanning of the stained hetero-oligomer bands on denatured gels, the 
composition of these oligomers is that of a hetero-trimer with #2 dimers associated to 
single " subunits. Additionally, the regulatory subunit is able to bind NADP
+
 with a 1:1 
stoichiometry, the cofactor enhancing " to #2-dimer binding affinity. Mutants lacking 
residues involved in NADP
+
 binding and N-terminal truncations of the " subunit were 
able to oligomerize with #2-dimers, although the kinetic properties appeared altered. 
These data together suggest a role for both parts of the sequence in the regulatory role 
exerted by the " subunit on catalysis. Moreover, preparation of a structural model for 
the hetero-oligomer, using the available crystal data, allowed prediction of the regions 
involved in " to #2-dimer interaction. Finally, the implications that the presence of 
different N-terminals in the " subunit could have on MAT II behavior are discussed on 
the light of the recent identification of several splicing forms of this subunit in 
hepatoma cells. 
 
Keywords: NADP
+
 binding site, methionine adenosyltransferase II, regulatory subunit, 
methionine affinity, association state, binding affinity. 
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INTRODUCTION 
 Mammalian methionine adenosyltransferase (MAT) II is the only hetero-
oligomer identified to date in the MAT family of enzymes (MAT, EC 2.5.1.6) that 
catalyze S-adenosylmethionine (AdoMet) synthesis using methionine and ATP as 
substrates [1]. This isoenzyme is composed of catalytic (#2) and regulatory (") subunits 
encoded by the MAT2A and MAT2B genes, respectively. The precise hetero-oligomer 
association state remains under debate, although it has been postulated to be tetrameric 
(#2")2, according to the results obtained from gel filtration chromatography and 
sedimentation velocity experiments [2-4]. Mammalian MAT isoenzymes, including 
MAT II, show dependency on Mg
2+
, stimulation by K
+
 and tripolyphosphatase activity. 
However, they differ in their affinities for methionine, MAT II exhibiting the highest, 
followed by MAT I and MAT III. The Vmax are also dissimilar, following the opposite 
trend [1]. Their response to AdoMet varies; MAT I (#14) and MAT II are inhibited by 
the reaction product, whereas AdoMet activates MAT III (#12)[1].  
 Classical studies identified MAT II in the cellular cytosol of extrahepatic and 
tumor cells, whereas MAT I and III were described as the hepatic isoenzymes [1, 5]. 
Development of liver cirrhosis and hepatocellular carcinoma (HCC) induces a switch in 
the expression of the isoenzymes in which MAT1A (encoding #1) expression is reduced 
and that of MAT2A increased [1, 6]. Given the differences in affinity and Vmax of these 
isoenzymes, this expression change leads to a reduction in the levels of AdoMet, the 
main methyl donor for cellular transmethylations, and among them some epigenetic 
modifications. Further confirmation of the importance that maintenance of AdoMet 
levels has for the cell was obtained upon production of knockout mice for MAT1A and 
GNMT (glycine N-methyltransferase). These mice exhibit low and high AdoMet 
concentrations, respectively, and spontaneously develop HCC [7, 8]. Recent reports 
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have shown both #1 and #2 proteins in the nuclear compartment, where AdoMet 
production was measured [9, 10]. Nuclear accumulation of MAT #1 correlated with 
histone 3 K27 trimethylation, whereas #2 was identified as a corepressor of MafK 
transcription factor. All these data together suggest that AdoMet synthesis is carried out 
close to where it is needed, hence the enzymes move to the nuclear compartment to 
provide methyl groups for epigenetic modifications [9-11]. 
 The role of the regulatory subunit has been explored mostly in lymphocytes and 
also after overexpression in other cell lines and bacteria [1]. The results obtained 
indicated that binding of the " subunit to #2 enhances the affinity for methionine (3.3 
µM vs. 80 µM) and decreases sensitivity to AdoMet inhibition [2, 12]. MAT2B 
expression has been shown to increase during liver cirrhosis and HCC development [1, 
13], but its expression not always follows that of MAT2A. Early stages of Wilson 
disease in the Long Evans Cinnamon rat model showed the MAT1A to MAT2A hepatic 
switch, but a strong reduction in MAT2B expression [14]. This effect was also observed 
in hepatoma H35 cells treated with copper, and was prevented by the addition of 
buthionine sulfoximine, an inhibitor of glutathione synthesis. 
 Catalytic #2 subunits preserve the average length ($390 residues), the conserved 
sequence blocks (including substrate binding motifs) and the folding (pdb code 2P02) 
that characterize this protein family [15, 16]. The crystal structure of #2 monomers 
shows the typical three-domain organization formed by nonconsecutive stretches of the 
sequence exhibited by # subunits from Bacteria to Eukarya. Association of #2 subunits 
into dimers occurs through a flat hydrophobic surface, and amino acids from both 
monomers constitute the two catalytic sites that locate between subunits opposed one to 
another. In contrast, the " subunit is a non-related protein, for which four splicing forms 
(named V1, V2, V2a, V2b) have been recently identified in hepatoma cells [17]. The 
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highest expression levels correspond to V1 and V2 forms that differ in the exon 1 used 
during transcription, thus leading to proteins that differ in their N-terminal sequences. 
Most studies carried out to date refer to the V1 splicing form of 334 residues, whose 
crystal structure has been recently obtained alone and in complex with NADP
+
 (pdb 
codes 2YDY and 2YDX, respectively). The V1 sequence exhibits 28% homology to 
bacterial enzymes that catalyze reduction of TDP-linked sugars, several nucleoside-
diphosphate sugar epimerases and other proteins involved in polysaccharide synthesis 
[1, 15], and hence the protein was classified as an oxidoreductase belonging to the 
PFAM 04321 family.  
 Most of the pathological processes in which MAT II is involved share 
production of a certain degree of oxidative stress that may be implicated in MAT II 
regulation as described for MAT I/III [1, 18]. The occurrence of NADP
+
 binding to the 
" subunit, postulated by the analysis of its sequence, and observed in one of the solved 
crystal structures (2YDX), also suggests this possibility. However, in this case the 
subunit involved might be " subunit rather than #2. Hence, the aims of this study were 
two, first to establish the MAT II association state and second to analyze the role of 
NADP
+
 binding on MAT II. 
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MATERIALS AND METHODS 
 1. Constructions and site directed mutagenesis. The cDNAs of human MAT2A 
and MAT2B were obtained by RT-PCR using the Superscript One-Step RT-PCR kit 
(Invitrogen) and total lymphocyte RNA kindly provided by Dr. López Trascasa of the 
Hospital Universitario La Paz (Madrid, Spain). In both cases cDNA synthesis was 
performed at 50ºC for 30 min. PCR was carried out for 35 cycles with 1 min annealing 
steps at 60ºC and 50ºC for MAT2A and MAT2B, respectively. The primers for cloning 
into pT7.7 included NdeI and EcoRI sites that appear underlined; their sequences were: 
5’-GGGAATTCCATATGAACGGACAGCTCAACGGCTT-3’ (sense) and 5’-CGGA 
ATTCAGCCTACGCCAACAAGTCTGGGGA-3’ (reverse) for MAT2A and 5’-GGGA 
ATTCCATATGGTGGGGCGGGAGAAAGAGCTCTCT-3’ (sense) and 5’-CGGAAT 
TCACAGGGCATGACTGCCCTTTAGT-3’ (reverse) for MAT2B. Sequences were 
verified by automatic sequencing at the Genomic Service of the Instituto de 
Investigaciones Biomédicas “Alberto Sols”. All the MAT2A ORFs cloned included two 
substitutions rendering #2 subunits with A233V and G193S mutations. The resulting 
plasmids were named pT7.7-MAT2A and pT7.7-MAT2B.  
 MAT2A was also cloned into the pOPTH vector, to produce the corresponding 
Met-Ala-(His)6-tagged protein. For this purpose, the ORF sequence was amplified using 
pT7.7-MAT2A as template and KOD polymerase (Novagen). Elimination of a BamHI 
internal site required a first PCR step that generated two fragments. Primers used for 
fragment 1 production were 5’-GGAGATATACATATGAACGGACAGCTCAACGG 
C-3’ (sense) and 5`-CTTTGGCATCAGGGTCCTGCTGAAGG-3´ (reverse), whereas 
fragment 2 synthesis utilized primers 5’-CCTTCAGCAGGACCCTGATGCCAAAG-3’ 
(sense) and 5´-CGCGGATCCTCAATATTTAAGCTTTTTGG-3’ (reverse). A second 
PCR step utilized a mixture of both fragments as templates together with the primers 5’-
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GGAGATATACATATGAACGGACAGCTCAACGGC-3’ (sense) and 5´-CGCGGAT 
CCTCAATATTTAAGCTTTTTGG-3’ (reverse) including NdeI and BamHI restriction 
sites (underlined), respectively. The final PCR program included 20 cycles with 1 min 
annealing steps at 55ºC. The resulting plasmid was named pOPTH-MAT2A.  
 The MAT2B ORF was also cloned into the pOPTG vector to produce a GST-
MAT " fusion protein (linker sequence ENLYFQGSH). For this purpose, the sequence 
was amplified from pT7.7-MAT2B using KOD polymerase and the primers 5´-GGAG 
ATATACATATGGTGGGGCGGGAGAAAGAGC-3´ (sense) and 5´-CGTGACGGAA 
GCTTCTAATGAAAGACCGTTTGTCTCC-3´ (antisense) including NdeI and HindIII 
restriction sites (underlined), respectively. The PCR program included 20 cycles with 1 
min annealing steps at 55ºC. The resulting plasmid was named pOPTG-MAT2B. 
Truncated MAT2B constructs were obtained by amplification of the desired sequence 
from the pT7.7-MAT2B vector using the same PCR conditions, the above described 
reverse primer and sense primers containing a NdeI restriction site for cloning into 
pOPTG. Primer sequences (sense only) for !S16 and !R29 were 5’-GGAGATATAC 
ATATGAGCTGTCGGCTGGTGGAGG-3’ and 5’-GGAGATATACATATGAGGAG 
GGTTCTGGTTACTGG-3’, respectively. 
 Site-directed mutagenesis was carried out in pOPTG-MAT2B using the 
QuikChange method (Stratagene) and the primers (changes underlined): 5’-GGTTAC 
TGGTGCCACTGTGCTTCTTGGCAGAGC-3’ and its complementary (G38V); 5’-CC 
TTAAATTTGTTTGGCAAAACAGCATTAGATGGAG-3’ and its complementary 
(Y159F/K163A). Sequences of all the plasmids were verified by automatic sequencing.  
 2. MAT #2 overexpression and purification. Competent BL21 (DE3) Codon 
Plus were transformed with pT7.7-MAT2A and grown in LBA medium at 37ºC until 
A600=0.3-0.4 when 0.5 mM IPTG (Ambion) was added and the culture transferred to 
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27ºC for 20 hours. The refolded-#2 protein was obtained from inclusion bodies using a 
procedure adapted from López-Vara et al. [19]. The changes refer to solubilization of 
the washed inclusion bodies with urea 8 M for 4 hours at 10ºC and dilution to 1 M urea 
at the first refolding step. Purification was carried out as previously described for MAT 
I/III [19]. 
 Alternatively, competent BL21 (DE3) cells were transformed with pOPTH-
MAT2A and grown in 2TY medium at 37 ºC until A600=0.6. In this case IPTG induction 
was carried out 18 hours at 16 ºC. The cell pellet was resuspended in 20 mM sodium 
phosphate pH 7.5 10 mM MgSO4, 5 mM DTT, 100 mM KCl (buffer A) and lysed in a 
French press. The soluble fraction was loaded into a His Trap HP 5 ml column (GE 
Healthcare) equilibrated in buffer A, followed by a washing step with buffer A 
containing 15 mM imidazol (50 ml). Elution was performed with a gradient (120 ml) 
from 15 to 300 mM imidazol in buffer A and 4 ml fractions collected. Samples of these 
fractions were loaded on SDS-PAGE gels that were stained to detect Met-Ala-(His)6-
#2. Fractions containing the fusion protein were pooled and loaded on a 5 ml Q HP 
column (GE Healthcare) equilibrated in 20 mM Tris/HCl pH 8, 10 mM MgSO4, 5 mM 
DTT (buffer B). Following washing with buffer B (50 ml), elution was performed with 
a gradient (120 ml) from 0 to 1M KCl in buffer B and 4 ml fractions collected. 
Fractions containing tagged-#2 were pooled, concentrated and loaded on a Superdex 
200 16/60 column equilibrated and run in buffer B containing 100 mM KCl at 1 ml/min. 
Fractions (1 ml) were collected and those containing the purified protein were pooled. 
 3- MAT " overexpression and purification. Competent BL21 Rosetta (DE3) 
pLysS were transformed with pOPTG-MAT2B and grown in 2TY medium at 37 ºC 
until A600=0.7. IPTG (0.5 mM) was added and the culture was grown for 16 hours at 16 
ºC. The cell pellet was resuspended in 50 mM Tris/HCl pH 7.5 containing 2 mM DTT 
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(buffer C), lysed in a French press and the soluble fraction loaded on a HiTrap Heparin 
HP 5 ml column (GE Healthcare) equilibrated in buffer C. The column was washed first 
with 50 ml buffer A plus 10% (v/v) Triton X-100 (Merck), followed by 50 ml of buffer 
C. Elution was performed with a 120 ml gradient from 0 to 1 M NaCl in buffer C and 4 
ml fractions collected. GST-MAT" was detected by SDS-PAGE staining of fraction 
samples. The fractions containing the fusion protein were pooled and loaded onto a 
GSTrap HP 5 ml column (GE Healthcare) equilibrated in buffer C containing 200 mM 
NaCl at 4 ºC (buffer D). After washing with buffer D (100 ml), cleavage was performed 
with home made TEV protease (protein:TEV mass ratio 80:1) that was loaded onto the 
column and left at 4 ºC o/n. The eluted " subunit (retaining the GSH linker sequence) 
was collected, diluted 3-fold with buffer D and reloaded on the heparin column to 
remove TEV protease. The purified " protein was pooled and made 50% (v/v) with 
glycerol for storage at -20ºC. Gel filtration chromatography of the " protein was carried 
out on a Superdex 200 16/60 column equilibrated and run in buffer 20 mM Tris/HCl pH 
8, 100 mM KCl, 10 mM Mg2SO4 at 1 ml/min and 1 ml fractions were collected. All 
mutants and truncated forms were obtained following the same protocol as the wild type 
protein.  
 4. In vitro production and isolation of MAT II hetero-oligomers. Purified 
refolded-#2 and " subunits (wild type, mutant or truncated) were dialyzed separately 
against 50 mM Tris/HCl pH 8, 10 mM MgSO4, 50 mM KCl (buffer E). Dialyzed 
samples were concentrated by ultrafiltration using AMICON PM-10 membranes to 
obtain protein concentrations of $1 mg/ml. Equimolar amounts of #2 and each " protein 
were mixed together and incubated for 1 hour at 4ºC before gel filtration 
chromatography on a Biogel A 1.5 m column (1.5 x 90 cm; BioRad) equilibrated in 
buffer E. Elution was carried out at 10 ml/h using buffer E and 3 ml fractions were 
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collected. The peak containing MAT II hetero-oligomers was identified by measuring 
A280 and MAT activity and collected. The presence of both subunits was confirmed by 
SDS-PAGE of the fractions. 
 5. Determination of MAT activity and kinetics. Activity assays were carried out 
at 37ºC as previously described [20], using 0.05 mg/ml protein concentrations and the 
standard MAT reaction mixture containing 5 mM methionine (Sigma) and 5 mM ATP 
(Sigma) in a final volume of 250 µl. Kinetics were performed using reaction mixtures 
containing 1-600 µM of the amino acid and 5 mM ATP (methionine kinetics) or 1-1500 
µM of the nucleotide and 5 mM methionine (ATP kinetics), NADP+ (Sigma) 50 µM 
was added to the protein mixture when required. 
 6. Analytical gel filtration chromatography.  Samples of refolded-#2 subunits 
and MAT II complexes (100 µl containing a minimum of 50 µg) were injected onto a 
Superose 12 10/300 GL gel filtration column (GE Healthcare) equilibrated and run in 20 
mM Tris/HCl pH 8, 10 mM MgSO4, 150 mM KCl. The flow rate was 0.3 ml/min and 
210 µl fractions were collected. MAT detection by activity measurements (100 µl) and 
Dot Blot using 1:1000 (v/v) chicken anti-MAT#2 (Abcam) were performed as 
previously described [21]. The protein standards (GE Healthcare and Sigma) used and 
their elution volumes were as follows: Dextran Blue (2000 kDa), 7.66 ml; apoferritin 
(443 kDa), 9.14 ml; "-amylase (200 kDa), 10.7 ml; alcohol dehydrogenase (150 kDa), 
11.27 ml; aldolase (158 kDa), 11.1 ml; conalbumin (75 kDa), 12.89 ml; ovalbumin (43 
kDa), 14.09 ml; carbonic anhydrase (29 kDa), 15.08 ml; and ATP (551 Da), 18.26 ml. 
The optimal separation range for this column according to the manufacturer’s brochure 
is 300 kDa to 1 kDa and the void volume 2000 kDa. The KAV for standards in the 
separation range was calculated using the following equation: 
  KAV = (Ve-Vo)/(Vf-Vo) 
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where, Ve is the elution volume of the standard; Vo, is the void volume (7.66 ml); and 
Vf, the final volume (18.26 ml). The calibration curve was obtained by representing KAV 
against the log of the molecular mass for each standard.     
 7. High-sensitivity isothermal titration calorimetry (ITC).  ITC experiments were 
performed with #2 and " subunits and the oxidized forms of the coenzymes NADPH 
and NADH using a high precision VP-ITC titration calorimeter (Microcal LLC, 
Northampton, MA). The purified " subunit (10 and 20 µM) was titrated with NADP+ 
(155 µM) or NAD+ (300 µM). Additionally, the #2 subunit (4-13 µM) was titrated with 
the " subunit (60-190 µM) in the absence or presence of NADP+ (300 µM). All 
measurements were performed in 20 mM Hepes/Na pH 7.5 containing 10 mM MgSO4, 
100 mM KCl and 2 mM DTT. The binding enthalpy (%H), the association constant (Ka) 
and the stoichiometry (n) were determined simultaneously, considering a model for a 
single class of binding sites, and the data used to calculate the Gibbs energy (%G), and 
the entropy (%S) of binding using well known equations [22-24]: 
 %G = -RT ln Ka 
 %G = %H- T%S 
 8. Mass spectrometry. Purified proteins (10 nmol) were extensively dialyzed 
against 75 mM ammonium acetate and lyophilized. Aliquots of these samples were 
subjected to mass spectrometry (MALDI-TOF) using an Applied Biosystems Voyager 
System 6214 at the facilities of the Instituto de Química-Física Rocasolano (CSIC). In 
addition, 20 µg of purified refolded-#2 were loaded in a SDS-PAGE gel, stained with 
Coomassie blue R250 (BioRad), the bands of interest excised and digested with 
sequencing grade trypsin (Promega) as described by Shevchenko et al. with minor 
modifications [25]. Disulfide bonds were reduced with 10 mM DTT for 1h at 57ºC and 
thiol groups alkylated with 55 mM iodoacetamide for 1h at RT. Peptides were desalted 
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using ZipTip C18 tips (Millipore) and peptide mass fingerprint conducted as previously 
described [26], using an Autoflex& mass spectrometer (Bruker Daltonics) in a positive 
ion reflector mode employing 2,5-dihydroxybenzoic acid as a matrix and an Anchor-
Chip& surface target (Bruker Daltonics). Peak identification and monoisotopic peptide 
mass assignation were performed automatically using Flex Analysis& software v. 2.2 
(Bruker Daltonics). Database searches were performed against the NCBI non-redundant 
protein sequence database (http://www.ncbi.nih.gov) using MASCOT 
(http://matrixscience.com)[27]. The selected search parameters were as follows: 
tolerance of two missed cleavages; carbamidomethylation (Cys) and oxidation (Met) as 
fixed and variable modifications, respectively; and setting peptide tolerance to 100 ppm 
after close-external calibration. A significant MASCOT probability score (p< 0.05) was 
considered as condition for successful protein identification. Additionally, the protein 
digest was resuspended in 0.1% (v/v) formic acid and analyzed by RP-LC-MS/MS in an 
Easy-nLC II system coupled to an ion trap LTQ-Orbitrap-Velos-Pro mass spectrometer 
(Thermo Fisher Scientific). The peptides were concentrated on-line by reverse phase 
chromatography using a Bio-Basic C18 RP precolumn (0.1 x 20 mm; Thermo Fisher 
Scientific), and then separated using a Bio-Basic C18 RP column (0.075 x 100 mm; 
Thermo Fisher Scientific) operating at 0.3 µl/min. The column was equilibrated in 0.1% 
(v/v) formic acid in water (solvent A) and the peptides were eluted using a 1 hour 
gradient from 5 to 40 % solvent B (0.1% formic acid, 80% acetonitrile). ESI ionization 
was done using a Nano-bore emitters Stainless Steel ID 30 µm interface (Proxeon). The 
Orbitrap resolution was set at 30000. Peptides were detected in survey scans from 400 
to 1600 amu (1 µscans) followed by 10 data dependent MS/MS scans, using an isolation 
width of 2 u (in mass-to-charge ratio units), normalized collision energy of 35% and 
dynamic exclusion applied during 30s. Peptide identification from raw data was carried 
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out using the SEQUEST algorithm (proteome Discoverer 1.3; Thermo Fisher 
Scientific). Search was performed against a homemade database containing MAT #2 
protein. The following constraints were used: tryptic cleavage after Arg and Lys, up to 
two missed cleavage sites; and tolerances of 10 ppm for precursor ions and 0.8 Da for 
MS/MS fragment ions; optional Met oxidation and Cys carbamidomethylation were 
allowed. Protein mass fingerprint was carried out at the Protein Chemistry facility of the 
Centro de Biología Molecular Severo Ochoa (CSIC), a member of the ProteoRed 
network. 
 9. Gel electrophoresis and densitometric scanning. Samples (30 µl) of different 
purification steps were prepared for electrophoresis using Laemmli buffer including 
10% (v/v) 2-mercaptoethanol and loaded into 10% SDS-PAGE gels. The 
electrophoresis standards (BioRad) were: phosphorylase B (97400), bovine serum 
albumin (66200), ovalbumin (45000), carbonic anhydrase (31000) and soybean trypsin 
inhibitor (21500). In addition, BlueStar Prestained Protein Markers (Nippon Genetics) 
were also loaded in a separate lane; those include proteins of the following sizes: 180, 
130, 100, 75, 63, 48, 35, 28, 17 and 10 kDa. Molecular mass calculations were carried 
out using Rf data for both types of standards to obtain the corresponding regression line. 
A representative example is given by logMr = (-0.883 x Rf) + 5.171. Staining was 
performed using Coomassie blue R250 (BioRad). Densitometric scanning of the bands 
was carried out using the ImageJ software 1.37v (http://rsb.info.nih.gov/ij/). 
 10. Protein concentration determinations. The protein concentration of the 
samples was measured routinely using the BioRad protein assay kit (BioRad) and 
bovine serum albumin as the standard.  
 11. Sequence analysis. Alignment of " subunit splicing forms versus V1 or 
members of the RED family was carried out with Blastp (http://blast.ncbi.nlm.nih.gov/). 
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Theoretical molecular mass calculations were carried out using the protein sequences 
and the Expasy tools (http://web.expasy.org/compute_pi/). 
 12. Analytical ultracentrifugation. Sedimentation equilibrium experiments were 
performed in a Beckman Optima XL-A ultracentrifuge using a Ti50 rotor and six 
channel centerpieces of Epon-charcoal (optical pathlength 12 mm). Samples of purified 
#2, " and MAT II (0.2-0.5 mg/ml) were centrifuged at 8000, 10000 and 14000 rpm at 
293 K. Radial scans at 280 nm were taken at 12, 14 and 16 hours. The three scans were 
identical, thus indicating that equilibrium conditions were reached. The weight-average 
molecular mass (Mw) of the proteins was determined using the program EQASSOC 
with the partial specific volume of #2, " and MAT II set to 0.7387, 0.7339 and 0.7366 
at 293 K as calculated from their amino acid composition. 
 13. N-terminal amino acid sequencing. Proteins ($20 µg) resolved in SDS-
PAGE gels were transferred to Hybond-P membranes (GE Healthcare), stained with 
Ponceau S staining and the bands of interest excised as previously described [19]. 
Sequencing was performed at the Proteomic Service of the Centro de Investigaciones 
Biológicas (CSIC). 
 14. Protein-Protein docking. Association of MAT II subunits was investigated 
using Clus-Pro (http://nrc.bu.edu/cluster), a fully automated web-based program for 
computational docking of protein structures [28]. For this purpose, the structures of #2 
(2P02) and " in the presence of NADP
+
 (2YDX) were submitted. The program 
evaluates billions of putative complexes, retaining a preset number with favorable 
surface complementarities. A filtering method is then applied for selection of structures 
with good electrostatic and desolvation free energies, ranking them according to their 
clustering properties. The models from the balanced option were selected from the 
ClusPro output, since there was no prior information as to the chemical nature of the 
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interaction, and the top ten proposed were analyzed. Finally, one was selected on the 
basis of scores and agreement with biochemical data. The model was submitted to crude 
dynamics and structure regularization using PHENIX [29] and analyzed with 
PROCHECK [30]. 
 15. Statistics. The Student’s t-test for unpaired samples was applied for 
statistical analysis of the kinetic data using GraphPad Prism v. 5.0 (GraphPad Software, 
San Diego). Differences were considered significant when p' 0.05. 
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RESULTS AND DISCUSSION 
 Characterization of recombinant catalytic !2 subunits. 
 The ORF encoded by the human MAT2A gene was amplified and cloned into 
different plasmids for heterologous overexpression. Sequencing of the amplicons from 
several PCR reactions of different RNA samples consistently included two mutations in 
the ORF, A233V and G193S, as compared to previously reported cDNAs [31]. The 
catalytic #2 subunits were produced in reduced amounts as soluble His-tagged proteins 
and in larger quantities as non-tagged proteins in inclusion bodies, from which they 
were refolded and purified (Fig. 1). Despite the high degree of identity among #1 and 
#2 amino acid sequences (85 %) the protocol developed for refolding of #1 subunits 
had to be slightly modified [19]. These modifications refer to an increase in the 
solubilization time and the first refolding step. Better yields were obtained when the 
dilution at this step was made to 1 M denaturant, and hence to a lower protein 
concentration. Purified refolded-#2 appeared as a double band on SDS-PAGE gels, 
their calculated size being 48 and 45.9 kDa according to the mobility of the standards 
(Fig. 1A). This $2 kDa difference was previously reported for #2 subunits either 
recombinant or purified from lymphocytic leukemia cells and ascribed to the presence 
of unknown post-translational modifications [2, 12]. The calculated size for the bands of 
lymphocytic origin was 53 (#2) and 51 kDa (#2’), as well as for the recombinant 
protein, values that are slightly larger than those obtained in the present study and by 
theoretical calculations [2, 12]. Purified preparations obtained from other origins such 
as bovine brain or erythrocytes showed single bands for #2 subunits on SDS-PAGE 
gels with calculated masses of 48 and 53 kDa, respectively [3, 4]. Recently, mass 
spectrometry studies identified several post-translational modifications in #2 subunits 
of mammalian origin, including acetylations [32], ubiquitinations [33] and 
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phosphorylations [34]. However, none of them has been associated with the discrepant 
mobilities observed. 
 In order to exclude the possibility of N-terminal proteolysis during #2 refolding 
and purification procedures, proteins were separated on SDS-PAGE gels, transferred 
and the bands excised. N-terminal sequencing of both bands confirmed retention of this 
part of the protein sequence. This result was also confirmed with purified recombinant 
Met-Ala-(His)6-#2, which showed a double band on the stained gels, indicating 
copurification of both species on His Trap HP columns. Mass spectrometry analysis 
(MALDI-TOF) of refolded-#2 showed a single peak of 43447 Da that corresponded to 
the expected mass for the complete subunit. However, a large proportion of the protein 
precipitated during sample preparation, and thus loss of one of the protein species could 
take place. Peptide mass fingerprint of #2 and #2’ bands separated on SDS-PAGE gels 
was then carried out. The same coverage, $50% of the MAT #2 sequence, was obtained 
for both bands (Fig. 2), with no difference that could be ascribed to the presence of a 
post-translational modification (Table 1). Results for both bands lack three residues of 
the C-terminal end that may be the result of trypsin digestion or an intrinsic difference 
between both #2 and #2’ bands. This last option alone cannot explain the apparent 2 
kDa difference between SDS-PAGE bands, but could contribute to changes in mobility 
due to post-translational modifications occurring in the remaining 50% of the sequence 
that could not be identified in our analysis. Additional sources of anomalous SDS-
PAGE mobilities have been reported in several opportunities, and related among others 
to the presence of structural elements resistant to standard methods of sample 
preparation or to ion complexes (i.e. neurocalcin) [35]. The data obtained with 
recombinant #2 and #2’ do not exclude the possibility that in mammalian cells post-
translational modifications occur in the peptides identified in the present study, neither 
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that they are the cause for the larger mass values obtained for #2 and #2’ purified from 
several tissues.  
 AdoMet synthesis requires production of oligomers with the correct orientation 
of their subunits, since catalytic sites locate at the interface of the monomers in the 
dimer with residues of each contributing to them [15, 36]. Therefore, analytical gel 
filtration chromatography of refolded-#2 was carried out and the protein detected by 
activity measurements and Dot-Blot (Fig. 3). The active protein exhibited an elution 
volume of 12.5 ml that corresponded to an 87 kDa oligomer, according to the elution 
profile of the markers (Fig. 3A and 3D). The calculated size is compatible with a 
dimeric association state, a result that is in agreement with previous data obtained for 
recombinant #2 [12]. However, injection of refolded-#2 samples at higher protein 
concentrations revealed the presence of two peaks, by both activity and Dot-blot, with 
calculated elution volumes of 11.44 and 12.50 ml, compatible with tetrameric and 
dimeric forms (Fig. 3B). Analytic ultracentrifugation of the samples confirmed the 
presence of tetrameric species above 0.2 mg/ml, hence suggesting a concentration 
dependent equilibrium (data not shown). Such behavior was not previously observed for 
recombinant #2, but described for refolded-#1 and other proteins such as NAD
+
-
dependent dehydrogenases and tryptophan synthase [21, 37]. Production of stable #1 
dimers and tetramers was shown to depend on the presence of a disulfide bond between 
residues 35 and 61 [21], but lack of cysteine at a position equivalent to C61 precludes 
such mechanism for #2 and many other members of the MAT family [16]. 
 Purified refolded-#2 showed a specific activity for the production of AdoMet of 
187.38 nmol/min/mg (Table 2). This value is in agreement with previously published 
data for the protein purified from lymphocytic cells (200 nmol/min/mg)[2], therefore 
ruling out a possible effect of the two mutations detected in our amplicons on activity. 
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In contrast, Met-Ala-(His)6-#2 showed a $5 fold reduction in the specific activity to 
35.19 nmol/min/mg,  thus suggesting  an effect of the N-terminal tag on this parameter. 
Addition of tags has been shown to affect both activity and expression of #1 subunits 
[10] and of other MATs [38], therefore given the high degree of identity among MAT 
catalytic subunits a similar behavior can be expected. The reason for a longer N-
terminal to decrease MAT specific activity is not clear, but may rely on subtle changes 
in folding affecting indirectly the active site. Based on these data the use of refolded-#2 
was preferred for further experiments. Kinetics for the substrates, methionine and ATP, 
were then carried out with the refolded protein, the calculated values appearing in 
Tables 3 and 4. The S0.5 values obtained for methionine were 5-fold higher than those 
previously reported by De La Rosa et al. for recombinant #2-dimers (80 µM), but no 
comparison regarding ATP affinity could be done since that study did not include such 
data [12].  
 Characterization of recombinant regulatory " subunits. 
 The ORF encoded by the human MAT2B gene (V1 form) was amplified and 
cloned for heterologous overexpression. Recombinant soluble regulatory " subunits 
were produced as GST fusion proteins that were excised with TEV protease in the last 
purification steps, the resultant protein exhibiting a calculated mass of 37.7 kDa on 
SDS-PAGE gels (Fig. 1B). This value is in agreement with the theoretical calculations 
of 37552 Da and the 38 kDa bands reported from mammalian cell purifications [2-4]. 
Our purified protein did not show coelution with E. coli # subunits as previously 
described for His-tagged " by LeGros et al. [39]. Gel filtration chromatography profiles 
of the purified " subunit showed an elution volume of 86 ml that correspond with a 
calculated 32 kDa protein according to the elution position of the markers and that is 
compatible with a monomeric association state (Fig. 4). In contrast, analytical 
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ultracentrifugation of the purified " subunit indicated an average particle size of 1.4, as 
referred to the theoretical molecular mass, hence suggesting a mixture of monomeric 
and dimeric species. Again, both techniques required the use of different protein 
concentration ranges, and hence the divergent behavior suggested the presence of the 
protein in a concentration dependent equilibrium. These results are in concordance with 
crystallization experiments in which monomeric (2YDY) and dimeric (2YDX) forms of 
the " subunit were obtained (Fig. 5). 
 Production and characterization of recombinant MAT II. 
 Incubation of equimolar amounts of purified refolded-#2 and " proteins allowed 
production of the hetero-oligomers containing catalytic and regulatory subunits (MAT 
II). Binding of refolded-#2 to " subunits induced a 5-fold reduction of MAT specific 
activity as compared to #2 dimers (Table 2) and MAT II purified from lymphocytic 
cells [2]. Increased affinities for both methionine ($10 fold) and ATP ($3.5 fold) were 
also detected as compared with #2 homo-oligomers (Tables 3 and 4), the S0.5 value for 
methionine being similar to that previously obtained for recombinant MAT II, and thus 
reproducing the effects described for the regulatory subunit in affinity [39]. The S0.5 for 
methionine shown by recombinant hetero-oligomers was $2 fold higher than that 
obtained with purified MAT II of different tissues (3.3-16 µM)[2, 12], although S0.5 
values for ATP were similar [2, 3]. Thus, recombinant hetero-oligomers reproduced the 
regulatory effects of the " subunit previously reported. 
 The hetero-oligomers were further characterized by analytical gel filtration 
chromatography. Elution occurs as a single peak at a volume (11.13 ml) corresponding 
to proteins of $170 kDa, according to the elution profile of the markers (Fig. 3C and 
3D). This behavior is compatible with a tetrameric association state with a 2:2 
catalytic/regulatory subunit ratio. A similar size, 175 and 160 kDa, was calculated for 
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purified MAT II from lymphocytes and bovine brain [2, 3]. This fact, together with the 
estimated size of the subunits obtained in SDS-PAGE, suggested three putative hetero-
oligomeric associations: (#2")2, #2#2’"2 and (#2’")2 [2]. In order to further analyze 
the hetero-oligomeric association we loaded samples of the peak obtained after gel 
filtration chromatography on SDS-PAGE gels (Fig. 1B). Densitometric scanning of the 
stained gels showed (#2+#2’)/" subunit ratios of 1.78 ± 0.17, also compatible with a 
trimeric association of the type #22", #2’2" or #2#2’". Data of hydrodynamic 
techniques, such as gel filtration chromatography, depend not only on the size, but also 
on the shape of the molecules analyzed. Thus, it is possible that the discrepant results 
observed with the same sample are due to the shape of the hetero-oligomer that favors 
elution at a smaller volume. Additional characterization of the MAT II oligomer was 
attempted by analytical ultracentrifugation, but protein aggregation during the process 
precluded this type of analysis (data not shown). Hence, to further clarify this point 
binding between #2 and " subunits was studied by ITC (Fig. 6). The interaction 
between both subunits was characterized by a high binding affinity (Ka = 2.7 x 10
8
 M
-1
) 
as compared to similar data for a variety of oligomers that range from 10
4
-10
16 
M
-1 
[40, 
41]. Additionally, the stoichiometry of the process (n = 0.45) suggested production of a 
heterotrimer with a 2:1 (#2+#2’) to " subunit ratio (Fig. 6A and Table 5). Therefore, all 
these results together indicate hetero-trimeric association of MAT II. 
 The role of NADP
+
binding to the regulatory " subunit. 
 While this work was in due course, a crystal structure of the " subunit including 
NADP
+
 was obtained (2YDX, Fig. 5), but the role of this compound has not been 
studied. Previous analysis of the " subunit sequence revealed high homology to NADP
+
 
binding proteins classified within the PFAM 04321 oxidoreductase family, its structure 
including a FAD/NADP
+
 Rossman fold predicted to start at residue 29 (Fig. 7)[1]. 
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Therefore, we decided to analyze NADP
+
 binding to the purified " subunit using ITC 
(Fig. 6B). The results indicated considerable NADP
+ 
binding affinity to this subunit (Ka 
= 5.8 x 10
5
 M
-1
) with a calculated dissociation constant of Kd = 1.7 µM (Table 5) and a 
1:1 stoichiometry (n=1). These values revealed the existence of a single NADP
+
 binding 
site per subunit, together with a dissociation constant in the range reported for other 
proteins binding this cofactor [23, 42-44]. Binding of NADP
+
 to the " subunit is 
entropically driven, being the enthalpic contribution very small and unfavorable (Table 
5). Similar measurements carried out with NAD
+
 revealed lack of binding to the protein, 
even in assays performed at different temperatures, thus indicating the specificity of the 
binding site for NADP
+ 
(Fig. 6B top inset). Analysis of the cofactor’s binding site 
observed in the reported crystal structure (2YDX) showed that the phosphate of NADP
+
 
is tightly coordinated with the " protein (Fig. 8). Moreover, the interaction produced 
between this phosphate and R62 seems essential, as this residue is making a network of 
interactions that conform the NADP
+
 binding pocket (Fig. 8A). All these observations 
are in agreement with the discrimination between NADP
+
 and NAD
+ 
cofactors observed 
in our experiments. 
 Effects of NADP
+
 binding to the regulatory subunit on the hetero-oligomer. 
 Binding of NADP
+
 to the regulatory " subunit may affect MAT II hetero-
oligomerization. Thus, in order to analyze this possibility we studied #2 to " subunit 
binding in the presence (Fig. 6C) or absence of the coenzyme using ITC (Fig. 6A, Table 
5). The data indicated that the process was more favorable when NADP
+
 was present (Ka 
( 4.0 x 10
8
 M
-1
), hence suggesting cooperativity between the cofactor and the " subunit 
while binding to #2. Although the calculated 1.5-fold increase in affinity may seem 
small, the value reported is at the limit for reliable estimation of the binding affinity, and 
hence the affinity increase due to the presence of NADP
+
 might be larger. Moreover, the 
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influence of the presence of NADP
+
 is more obvious if the enthalpic and entropic 
contributions are compared; the presence of NADP
+
 makes the binding enthalpy less 
favorable and the binding entropy less unfavorable (Table 5). Therefore, binding of " 
and #2 subunits might proceed together with a conformational change that could be 
favored by previous production of the ":NADP
+
 complex. Analysis of this possibility by 
comparison of crystal structures of " in the absence or presence of the cofactor showed 
that three regions of the polypeptide chain became ordered when NADP
+
 is bound (Fig. 
5). Those are: F60-A77 (region A), A95-N113 (region B) and D325-F333 (region C); 
among them only regions A and B interact directly with the cofactor, whereas regions A 
and C are involved in " to " interactions in the dimer.  
 The increased binding affinity between catalytic and regulatory subunits shown 
in the presence of NADP
+
 could also affect MAT II kinetics. Therefore, purified MAT 
II was incubated in the presence of 50 µM NADP+ and kinetics for both substrates, 
methionine and ATP, performed. No significant changes were induced by the cofactor 
in Vmax or the affinities for both substrates (Tables 2-4). However, this lack of effect 
could rely on the preservation of NADP
+
 binding to the " subunit during purification, 
before hetero-oligomer production. To analyze this option mutants on the putative 
cofactor’s binding site were prepared, including G38V in the Wierenga’s motif 
(GXXGXXG) and the double mutant Y159F/K163A of the putative catalytic triad of 
the RED family of reductases/epimerases/dehydrogenases (Fig. 7 and 8B). 
Heterologous expression of G38V yielded no soluble protein, thus being excluded from 
the study. On the other hand, purified Y159F/K163A-" subunits appeared as a band of 
37.7 kDa on SDS-PAGE gels (Fig. 1C), in agreement with theoretical calculations [12]. 
NADP
+
 binding to this double mutant was then analyzed by ITC and a Kd > 150 µM 
was calculated (Fig. 6B bottom inset). Therefore, these substitutions lead to a dramatic 
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reduction (>50-fold) in the binding affinity as compared to the wild type " subunit (Kd 
= 1.7 µM), hence indicating severe disruption of NADP+ binding in the mutant. 
Association of #2 subunits with Y159F/K163A-" was not precluded and the hetero-
oligomers produced are referred as mutant MAT II. Analysis of these hetero-oligomers 
by analytical gel filtration chromatography showed elution volumes of $11.5 ml, 
corresponding to proteins of $165 kDa, according to the elution volume of the 
standards. Again, densitometric scanning of SDS-PAGE bands of the hetero-oligomers 
indicated a 2:1 ratio for (#2+#2’) and mutant " subunits, hence indicating preservation 
of the trimeric association state previously shown. The effects of mutant " subunits on 
kinetics were then analyzed, the results indicating a slight increase in Vmax for the 
hetero-oligomers as compared to wild type MAT II that are not statistically significant 
(Table 2). Affinities for the substrates were decreased in mutant MAT II, the effect 
being significant only for ATP, ~2-fold (Tables 3 and 4). Addition of NADP
+
 to mutant 
MAT II did not modify Vmax or the affinities for the substrates (Tables 2-4), as expected 
for a mutant lacking key residues for cofactor binding. 
 Construction of MAT II structural models by docking of !2 and " subunits. 
 To obtain further insight within the role of NADP
+
 in the association of " to #2 
subunits, models of the MAT II hetero-oligomer were prepared using the ClusPro server 
for protein-protein docking. Noteworthy, all the proposed output models showed the 
three " subunit regions ordered upon NADP
+
 binding at the hetero-oligomer interface. 
According to our data, only models satisfying the 2:1 stoichiometry for #2 and " 
subunits would have biochemical sense, and hence the one showing the best scores was 
selected for further analysis (Fig. 9). The proposed model is coherent with the increased 
affinity for association of both types of subunit in the presence of NADP
+
, since the 
cofactor seems to stabilize the putative interface regions, A and C. In addition, 
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participation of #2 central domains in the interaction with " would lead to changes in 
the active site configuration that could explain variations in enzyme kinetics. Such a 
role of central domains has been previously demonstrated in MAT #1, whose level of 
oligomerization depends on the stabilization of these domains, hence the differences in 
substrate affinities shown by MAT I (tetramer) and III (dimer) [21, 36]. Therefore, the 
model proposed for MAT II would point to a similar mechanism of specific modulation. 
 Significance of different splicing forms of the " subunit in the role of NADP+. 
 Recently, Yang et al. reported the existence of four splicing forms of the 
regulatory " subunit in hepatoma cells, V1 and V2 showing the highest expression 
levels [17]. These two splicing forms derive from the use of a different exon 1, hence 
showing a specific N-terminal sequence, but preserving the Rossman fold, and thus, the 
ability to bind NADP
+
 (Fig. 10). The other difference relies on their chain length that 
varies from 334 residues for V1 to 323 amino acids for V2, due to a shorter exon 1 
encoding the N-terminal for this last form. Therefore, to obtain insight in the role of the 
N-terminal in hetero-oligomer assembly we prepared a truncated form of the " subunit 
on pOPTG-MAT2B. This truncated " contained the conserved sequence between V1 
and V2 splicing forms, including the Rossman fold (starting at residue 29). This %R29 
protein was expressed in E. coli, but was prone to aggregation, and hence excluded from 
the study. Therefore, a second N-terminal deletion was obtained, according to the 
spontaneous proteolysis detected in initial experiments with a non-tagged recombinant 
protein. This truncated protein (%S16), starting at residue 16 of V1, was purified 
following the same protocol as for wild type ". The protein exhibited a 34.8 kDa band 
on SDS-PAGE gels and associated to refolded-#2, leading to the corresponding hetero-
oligomer that was named truncated MAT II (Fig. 1D). Analytical gel filtration 
chromatography of the truncated MAT II showed elution at $11.5 ml, compatible with a 
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protein of $165 kDa according to the elution volume of the standards. Densitometric 
scanning of SDS-PAGE bands of the hetero-oligomer again indicated a refolded-#2 to 
truncated-" ratio of 2:1, suggesting production of hetero-trimers.  
 The effect of N-terminal deletion on kinetics was then explored. A significant 
increase in Vmax (1.7-fold) was observed, together with decreases in the affinities for the 
substrates as compared to wild type MAT II (Table 2-4). Reductions in affinity were 
larger for methionine (5-fold) than for ATP (2-fold), indicating a stronger effect on the 
methionine binding site. These results suggest a role for the N-terminal of the " subunit 
in the regulatory effects of #2 catalysis that have been described to date [1]. 
Comparison of kinetic data of MAT II with those of mutated (lacking the NADP
+
 
binding site) and truncated hetero-oligomers, showed that changes in Vmax and affinities 
for the substrates are larger in the truncated MAT II and intermediate for the mutant 
MAT II, which showed more variability. Thus, both, elimination of NADP
+
 binding 
residues and of the N-terminal, modify kinetics of AdoMet synthesis in #2. However, 
significant effects on Vmax are only shown in truncated MAT II, thus suggesting that the 
role of the N-terminal of the regulatory subunit in favoring the conformational changes 
of the active site leading to catalysis is more important [15, 45]. Unfortunately, the 
available crystal structures for the " subunit have been obtained from constructs starting 
at residue 28, hence precluding analysis of the influence that the N-terminal segment 
may have on the active site. 
 Truncated " subunits conserve the NADP
+
 binding site and hence the effects of 
the cofactor on kinetics could be explored. A slight decrease in Vmax was induced by 
addition of the cofactor that did not change the affinities for the substrates in truncated 
MAT II (Tables 2-4). Again, these data suggested a role of NADP
+
 binding in the 
effects exerted by " subunits on the active site, although preservation of NADP
+
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binding during purification of truncated subunits might be the cause of the minimum 
changes detected. Kinetic results together highlight the role of the N-terminal of V1 in 
catalysis and show the importance of both the N-terminal and NADP
+
 binding in the 
reported changes induced by the " subunit in MAT II [2, 12]. Therefore, it can be 
deduced that V1, V2 and V2a splicing forms that contain the NADP
+
 binding site will 
be susceptible of regulation by the cofactor, whereas such a regulation will not occur in 
V2b forms lacking this site (Fig. 10)[6]. Additionally, the expression of " splicing 
forms with different N-terminals may provide another level of control of #2 catalysis, a 
fact that could acquire additional relevance for tumor cells that are known to depend on 
methionine for growth [46]. 
 In summary, our results support the trimeric association state of the MAT II 
hetero-oligomer. ITC data indicate that formation of the #22" complex is enthalpically 
driven and characterized by high affinity. Moreover, production of the "/NADP
+ 
complex is characterized by moderate affinity and the #22" oligomer is further 
strengthened when NADP
+ 
is bound
 
to the regulatory " subunit. Therefore, production 
of looser hetero-oligomers may be the cause of the intermediate kinetic effects observed 
in a mutant with a severe disruption of cofactor binding. Finally, the N-terminal end of 
" subunits is important for their regulatory role in catalysis, acting especially on the 
affinities for the substrates. Thus, differences in this region between splicing forms 
would provide an additional regulatory mechanism for MAT II. 
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FIGURE LEGENDS 
 Figure 1. Production of recombinant proteins and purification steps. The 
upper part of the figure shows a scheme of the purification steps followed to prepare the 
three types of hetero-oligomers obtained in this work. The numbers indicate the 
corresponding lane of the representative stained gels shown below. Panel A shows a 
representative SDS-PAGE gel used for molecular mass estimation, including two sets of 
standards as indicated in the Materials and Methods section. Samples (30 µl) of key 
purification steps to produce wild type (B), mutated (C) and truncated MAT II (D) were 
prepared under standard reducing conditions for SDS-PAGE electrophoresis. Gel lanes 
correspond to: (1) refolded #2 (10 µg); (2) Q-Sepharose collected peak (10 µg); (3) 
concentrated Q-Sepharose peak (25 µg); (4) standards; (5) purified hetero-oligomer (10 
µg); and (6) purified wild type (10 µg), mutant (5 µg) or truncated " subunit (10 µg). 
Panels B-D show only the relevant sections of the stained gels for each type of 
purification; the positions for the 45 and 31 kDa protein standards are indicated on the 
side of the gels. Dots indicate places where gel lanes have been cropped for clarity.  
 Figure 2. MAT #2 sequence identified by peptide mass fingerprint using 
LC-MS/MS. The figure shows the amino acid sequence of human MAT #2, where the 
peptides identified by mass spectrometry are indicated. Blue squares highlight the two 
mutations detected in the ORF (underlined). Pink squares indicate the peptides 
identified with high scores in both #2 and #2’ bands. The green square indicates a 
peptide identified in both bands, but showing higher score for #2’ than for the #2 band. 
The sequence coverage is $50% of the total protein sequence. 
 Figure 3. Analytical gel filtration chromatography of MAT proteins. The 
figure shows gel filtration chromatography profiles of purified MAT forms followed by 
activity measurements (!) and densitometric scanning of Dot Blots incubated with anti-
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MAT#2 ("). The elution behavior of the #2 subunit is depicted in panels A (50 µg) and 
B (200 µg), and that of the MAT II hetero-oligomer including the wild type " subunit 
appears in panel C. Panel D shows a representative regression line for the standards 
used in column calibration [log Mr = (-2.085 x KAV) + 5.903]. The elution volume of 
representative standards is indicated by a vertical bar and specified in the Materials and 
Methods section. 
 Figure 4. Gel filtration chromatography of the "  subunit. The purified wild 
type " subunit was analyzed on a Superdex 200 16/60 gel filtration column and the 
elution followed by A280. Vertical bars indicate the elution position of relevant 
standards. The elution volume of all the markers used was: dextran blue (2000 kDa) 
39.4 ml; apoferritin (443 kDa) 52.3 ml; "-amylase (200 kDa) 59.5 ml; alcohol 
dehydrogenase (150 kDa) 64.3 ml; bovine serum albumin (66.2 kDa) 71.6 ml; and 
cytochrome c (12.4 kDa) 93 ml. 
 Figure 5. Comparison of the structures of human "  subunits in free and 
NADP
+
 bound states. The figure depicts the structure of free " subunits (white; 2YDY) 
and that of the NADP
+
 bound state (red; 2YDX). Cofactor and resveratrol molecules are 
shown as sticks with coloured carbon (black), nitrogen (red), phosphorus (orange) and 
oxygen (blue) atoms. Three regions not visible in the apoenzyme and ordered upon 
NADP
+
 binding are highlighted: F60-A77 (A), A95-N113 (B), and D325-F333 (C); 
only A and B regions are linked to NADP
+
. On the right the surface of the " dimer is 
shown as found in the NADP
+
 bound crystal structure, illustrating location of A and C 
regions in the dimer interface. 
 Figure 6. Isothermal titration calorimetry of MAT subunits in the presence 
or absence of NADP
+
. The figure shows representative titration experiments carried 
out with the wild type regulatory " subunit to characterize binary and tertiary binding 
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with #2 subunits and/or NADP
+
. Panel A depicts titration of #2 (13.4 µM in the cell) 
and " subunits (190 µM in the syringe). Panel B shows titration of the " subunit (9.8 
µM in the cell) and NADP+ (155 µM in the syringe); the insets show titrations using the 
" subunit (20 µM) and 300 µM NAD+ (top) and the Y159F/K163A-" subunit (20 µM) 
and 330 µM NADP+ (bottom). The very low affinity observed for the mutant precluded 
a precise estimation of the binding affinity, and hence only a lower limit for the 
dissociation constant could be determined. Panel C illustrates titration of #2 (4.3 µM in 
the cell) and " subunits (62.4 µM in the syringe) in the presence of NADP+ (300 µM in 
both the cell and the syringe). All measurements were performed at 25ºC as described in 
the Materials and Methods section. 
 Figure 7. Sequence comparison of the "  subunit (V1 form) with relevant 
members of the RED family. The figure shows an alignment of sequences for Dtdp-6-
deoxy-L-lyxo-4-hexulose reductase (1N2S), Dtdp-glucose 4,6-dehydratase (1BXK) and 
the " regulatory subunit of MAT II. Conserved residues of the GXXGXXG phosphate 
binding motif and the catalytic triad (SXNYXXXK) appear in blue. 
 Figure 8. The NADP
+
 binding site in the "  subunit.  The figure shows the 
structure of the NADP
+ 
site with the protein residues shown as wheat sticks. Colour 
codes are as in Figure 4. Panel A depicts recognition of the phosphate moieties, 
showing that segment A is involved in NADP
+
/NAD
+ 
discrimination by linking the 
additional phosphate group. This phosphate is linked to R62 (region A) and establishes 
a strong network of atomic interactions that connects to R97 (region B), conforming the 
NADP
+
 binding site. Panel B shows a detail of the residues that bind NADP
+
 and have 
been mutated in this work. 
 Figure 9. Structural model of the MAT II trimer. A putative model of the 
MAT II hetero-oligomer was obtained with ClusPro using available coordinates for #2 
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(2P02) and " (2YDX) subunits. The #2 subunits in the dimer are shown as cream and 
black cartoons. Each #2 monomer consists of N-terminal, central and C-terminal 
domains, both subunits being related by a 2-fold symmetry axis. The " subunit is 
represented as a green surface, with A, B and C regions highlighted in red. The hetero-
oligomer interface is formed by central domains of both #2 monomers and regions A, B 
and C from the regulatory " subunit. Only models displaying " interacting to #2 central 
domains, therefore located on its 2-fold axis, would be consistent with a 2:1 
stoichiometry in the hetero-oligomer. 
 Figure 10. Sequence alignment of regulatory subunit splicing forms. 
Sequences of the four splicing forms reported to date for the regulatory " subunit of 
MAT II in hepatoma cells were aligned against the most abundant V1 form (334 
residues). The figure shows underlined the residues truncated in the %S16 protein used 
in this study. In addition, several differences among splicing forms are also indicated: 
the N-terminal differences (orange), the sequence lacking in V2a (pink) and V2b 
(green), and the putative NADP
+
 binding motifs (blue). 
 
 
 
 
 
 
 
 
 
 
 35 
Table 1 
Results of peptide mass fingerprint of MAT !2 bands.  Purified refolded-!2 was loaded in SDS-PAGE gels, the two bands (!2 and !2´) 
observed after staining were excised and digested with trypsin. Peptides were desalted and subjected to MALDI-TOF to obtain the corresponding 
mass fingerprint. Database searches were performed with MASCOT and successful protein identification was considered when p < 0.05.  
RESULTS FOR !2  RESULTS FOR !2’ 
Mass Mr Dev Range P sequence Mass Mr Dev Range P sequence 
     561.231 -0.039 308-312 0 GGLCR 
600.314 -0.046 164-168 0 LAELR 600.307 -0.052 164-168 0 LAELR 
628.240 -0.045 98-102 0 GFDYK 628.292 0.006 98-102 0 GFDYK 
708.299 -0.056 293-299 0 SAAYAAR 708.332 -0.023 293-299 0 SAAYAAR 
     717.280 0.009 308-313 0 GGLCRR 
724.432 -0.028 193-199 0 GAVLPIR 724.429 -0.031 193-199 0 GAVLPIR 
756.460 -0.001 164-169 1 LAELRR 756.419 -0.042 164-169 1 LAELRR 
     793.368 -0.029 75-81 0 AAVDYQK 
803.407 -0.058 368-373 0 KPIYQR      
895.390 -0.050 286-292 1 DYTKVDR 895.410 -0.030 286-292 1 DYTKVDR 
978.418 -0.049 374-382 0 TAAYGHFGR 978.428 -0.039 374-382 0 TAAYGHFGR 
1020.350 -0.102 89-97 0 HIGYDDSSK 1020.410 -0.041 89-97 0 HIGYDDSSK 
1103.435 -0.094 383-391 0 DSFPWEVPK 1103.466 -0.062 383-391 0 DSFPWEVPK 
1231.541 -0.083 383-392 1 DSFPWEVPKK 1231.535 -0.089 383-392 1 DSFPWEVPKK 
1284.671 -0.059 352-362 0 NFDLRPGVIVR      
1360.657 -0.082 62-74 0 TGMILLAGEITSR 1360.620 -0.118 62-74 0 TGMILLAGEITSR 
1367.596 -0.054 182-192 0 TQVTVQYMQDR 1367.523 -0.128 182-192 0 TQVTVQYMQDR 
1382.681 -0.050 170-181 0 NGTLPWLRPDSK 1382.636 -0.094 170-181 0 NGTLPWLRPDSK 
1383.674 0.029 182-192 0 TQVTVQYMQDR 1383.611 -0.034 182-192 0 TQVTVQYMQDR 
1387.732 -0.050 363-373 1 DLDLKKPIYQR 1387.663 -0.119 363-373 1 DLDLKKPIYQR 
1412.771 -0.054 351-362 1 KNFDLRPGVIVR 
 
 
 
 
 
 
 
 
 
1412.722 -0.103 351-362 1 KNFDLRPGVIVR 
 36 
1443.718 -0.029 250-264 0 FVIGGPQGDAGLTGR 1443.642 -0.105 250-264 0 FVIGGPQGDAGLTGR 
1571.809 -0.033 250-265 1 FVIGGPQGDAGLTGRK 1571.741 -0.101 250-265 1 FVIGGPQGDAGLTGRK 
1630.673 -0.054 89-102 1 HIGYDDSSKGFDYK 1630.622 -0.105 89-102 1 HIGVDDSSKGFDYK 
1805.855 -0.003 235-249 0 YLDEDTIYHLQPSGR 1805.795 -0.063 235-249 0 YLDEDTIYHLQPSGR 
1948.944 0.000 266-285 0 IIVDTYGGWGAHGGGAFSGK 1948.806 -0.137 266-285 0 IIVDTYGGWGAHGGGAFSGK 
     2064.029 0.043 374-391 1 TAAYGHFGRDSFPWEVPK 
2077.058 0.020 265-285 1 KIIVDTYGGWGAHGGGAFSGK 2076.911 -0.127 265-285 1 KIIVDTYGGWGAHGGGAFSGK 
     2191.913 -0.167 374-392 2 TAAYGHFGRDSFPWEVPKK 
     2408.073 -0.073 200-219 0 VHTIVISVQHDEEVCLDEMR 
2456.189 0.013 266-289 1 IIVDTYGGWGAHGGGAFSGKDYTK 2456.043 -0.133 266-289 1 IIVDTYGGWGAHGGGAFSGKDYTK 
     2562.305 0.019 103-125 0 TCNVLVALEQQSPDIAQGVHLDR 
2584.297 0.026 265-289 2 KIIVDTYGGWGAHGGGAFSGKDYTK 
 
2584.246 -0.025 265-289 2 KIIVDTYGGWGAHGGGAFSGKDYTK 
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Table 2 
 MAT activity data of #2 homo- and hetero-oligomers. The table shows Vmax 
data of #2 homo-dimers and hetero-oligomers composed by: #2 and wild type " (MAT 
II); #2 and Y159F/K163A-" (mutant MAT II); and #2 and %S16 " subunit (truncated 
MAT II). The results shown are the mean ± SD of a minimum of three independent 
experiments carried out in triplicate that were considered significant when p' 0.05 (*). 
 
 Vmax (nmol/min/mg) 
 - NADP
+ 
p value 
vs. MAT II 
+ NADP
+ 
p value 
+/- NADP
+ 
#2 187.38 ± 27.37   0.01* - - 
MAT II 33.95 ± 7.52 -   36.53 ± 10.06 0.74 
Mutant MAT II   45.76 ± 11.02 0.16   58.73 ± 20.30 0.26 
Truncated MAT II  58.00 ± 2.36  0.01* 43.56 ± 7.51   0.04* 
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Table 3 
 Methionine kinetics of #2 homo- and hetero-oligomers. The table shows the 
calulated S0.5 values for methionine of #2 homo-dimers and hetero-oligomers composed 
by: #2 and wild type " (MAT II); #2 and Y159F/K163A-" (mutant MAT II); and #2 
and a %S16 " subunit (truncated MAT II). S0.5 refers to the concentration of substrate at 
which half the Vmax is achieved. The results shown are the mean ± SD of a minimum of 
three independent experiments carried out in triplicate and were considered significant 
only when p' 0.05 (*). 
 
 
 S0.5
Met 
 (µM) 
 - NADP
+ 
p value 
vs. MAT II 
+ NADP
+ 
p value 
+/- NADP
+ 
#2   395.44 ± 60.12   0.01* - - 
MAT II     35.19 ± 29.43 - 29.74 ± 2.16 0.82 
Mutant MAT II     84.00 ± 58.24 0.27 70.51 ± 5.93 0.79 
Truncated MAT II  152.33 ± 1.04  0.02* 132.42 ± 23.81 0.21 
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Table 4 
 ATP kinetics for #2 homo- and hetero-oligomers. The table shows the 
calulated S0.5 values for ATP of #2 homo-dimers and hetero-oligomers composed by: 
#2 and wild type " (MAT II); #2 and Y159F/K163A-" (mutant MAT II); and #2 and a 
%S16 " subunit (truncated MAT II). S0.5 refers to the concentration of substrate at which 
half the Vmax is achieved. The results shown are the mean ± SD of a minimum of three 
independent experiments carried out in triplicate and were considered significant only 
when p' 0.05 (*). 
 
 
 S0.5
ATP
 (µM) 
 - NADP
+ 
p value 
vs. MAT II 
+ NADP
+ 
p value 
+/- NADP
+ 
#2 254.40 ± 66.18 0.01* - - 
MAT II   67.49 ± 15.87 -   74.52 ± 12.56 0.53 
Mutant MAT II 124.53 ± 32.20 0.01* 142.37 ± 32.21 0.48 
Truncated MAT II  150.85 ± 81.37 0.05* 154.34 ± 34.86 0.95 
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Table 5 
Thermodynamic parameters for MAT II interactions. The purified MAT " subunit 
was titrated with NADP
+
 or the #2 subunit (in the presence or absence of NADP
+
) using 
ITC and the parameters included in the table were obtained. Relative errors in Ka and Kd 
were typically 20%; absolute errors in %H and -T%S were 0.3 kcal/mol. 
 
 NADP
+
)  "  #2)  "  #2)  "
a
 
Ka (M
-1
) 5.8 ± 0.6 x 105 2.7 ± 0.3 x 108 >4.0 ± 0.4 x 108 
Kd (M) 1.7 ± 0.2 x 10
-6
 3.7 ± 0.4 x 10-9 <2.5 ± 0.3 x 10-9 
%G (kcal/mol) -7.9 ± 0.1 -11.5 ± 0.1 <-11.7± 0.1 
%H (kcal/mol)  0.8 ± 0.2 -28.3 ± 0.2  -22.2 ± 0.2 
-T%S (kcal/mol) -8.7 ± 0.2  16.8 ± 0.2  <10.5± 0.2 
n  0.99 ± 0.02    0.45 ± 0.02      0.45 ± 0.02 
 
a
 Data in the presence of NADP
+
 (300 µM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 










